Multi-center randomized controlled trial of gemcitabine in combination with gimeracil/oteracil/tegafur compared with gemcitabine alone in patients with advanced nonresectable pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms GEMSAP
- 18 Jan 2014 Pooled results for prognostic factors from GEST, GEMSAP, and JACCRO PC-01 presented at the 2014 Gastrointestinal Cancers Symposium.
- 07 Jun 2011 Final overall survival results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.
- 04 Jun 2010 Results from first analysis have been presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).